Evogenom Oy received significant funding
Evogenom Oy, a Jyväskylä-based Company from Finland producing comprehensive consumer genetic tests, has secured significant funding. The funding round included Trind VC as well as a group of other investors who strongly believe in the potential and future growth of Evogenom Oy.
Trind VC is a venture capital firm that focuses on consumer-oriented growth companies. The company’s investment strategy is strongly data-driven, and they seek to help businesses grow in the long term.
Hannu Tolvanen, CEO of Evogenom Oy, commented with satisfaction: “This funding gives us strength for sales and internationalization. We are excited about future opportunities and about being able to provide our services to an even wider customer base. With this funding, we can develop our product portfolio and strengthen our position in the market.”
Evogenom Oy is known for its innovative genetic tests, which provide consumers with valuable insights into wellbeing, recovery, sleep, exercise, nutrition, and medication. The company’s uniqueness lies in its ability to combine scientific accuracy with user-friendliness, making genetic testing accessible and understandable for everyone.
The genetic testing market is experiencing significant growth, and Evogenom Oy is ready to take advantage of the opportunities this growth presents. Increasing numbers of consumers are interested in their wellbeing, and the need for reliable and easy-to-use tools has become widely recognized.
Antti Seppä appointed as new Chairman of the Board
In May 2024, the Board of Directors of Evogenom Oy appointed Antti Seppä as its new Chairman. Seppä is currently CEO of Docue and is also known as the former CEO of Admicom Oyj.
Chairman of the Board Antti Seppä commented: “My interest in human physiology first led me to learn about Evogenom, where I quickly recognized its international scalability potential. When I heard about the funding round and the participation of Trind VC, it was an easy decision to join the journey in the role of Chairman.”